The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer
Extracellular Vesicles and Circulating Nucleic Acids · 28.02.2025 · 6 (1) · 128-40
DOI: 10.20517/evcna.2024.51 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 28.02.2025. Verfasst von Vanesa García-Barberán und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlo…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Artificial intelligence (AI) is revolutionizing scientific research by facilitating a paradigm shift in data analysis and discovery. This transformation is characterized by a fundamental change in scientific methods and concepts due to AI’s ability to process vast datasets with unprecedented speed and accuracy. In breast cancer research, AI aids in early detection, prognosis, and personalized treatment strategies. Liquid biopsy, a noninvasive tool for detecting circulating tumor traits, could ideally benefit from AI’s analytical capabilities, enhancing the detection of minimal residual disease and improving treatment monitoring. Extracellular vesicles (EVs), which are key elements in cell communication and cancer progression, could be analyzed with AI to identify disease-specific biomarkers. AI combined with EV analysis promises an enhancement in diagnosis precision, aiding in early detection and treatment monitoring. Studies show that AI can differentiate cancer types and predict drug efficacy, exemplifying its potential in personalized medicine. Overall, the integration of AI in biomedical research and clinical practice promises significant changes and advancements in diagnostics, personalized medicine-based approaches, and our understanding of complex diseases like cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid 28040, Spain.
- Facultad de Medicina, Universidad Alfonso X el Sabio, Madrid 28691, Spain.
Zitieren
APA
García-Barberán, V., Gómez Del Pulgar, M. E., Guamán, H. M., & Benito-Martin, A. (2025). The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer. Extracellular Vesicles and Circulating Nucleic Acids, 6(1), 128-40. https://doi.org/10.20517/evcna.2024.51
Vancouver
García-Barberán V, Gómez Del Pulgar ME, Guamán HM, Benito-Martin A. The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer. Extracellular Vesicles and Circulating Nucleic Acids. 2025;6(1):128-40. doi:10.20517/evcna.2024.51
BibTeX
@article{GarcaBarbern2025,
author = {García-Barberán, Vanesa and Gómez Del Pulgar, María Elena and Guamán, Heidy M and Benito-Martin, Alberto},
title = {The times they are AI-changing: AI-powered advances in the application of extracellular vesicles to liquid biopsy in breast cancer},
journal = {Extracellular Vesicles and Circulating Nucleic Acids},
year = {2025},
volume = {6},
number = {1},
pages = {128--40},
doi = {10.20517/evcna.2024.51}
}
EUVIMED